Last reviewed · How we verify

NCT04352517

Influence Physical Activity Psychological Responses COVID-19 Pandemic

Completed Last updated 21 February 2021
What this trial tests

trial testing Online Survey in Sedentary Behavior in 3,500 participants. Completed in 30 September 2020.

Timeline
16 March 2020
Primary endpoint
31 August 2020
30 September 2020

Quick facts

Lead sponsorUniversity of Extremadura
StatusCompleted
Study typeOBSERVATIONAL
Enrollment3,500
Start date16 March 2020
Primary completion31 August 2020
Estimated completion30 September 2020
Sites3 locations across Chile, Brazil, Uruguay

Drugs / interventions tested

Conditions studied

Sponsor

University of Extremadura

Who can join

18 and older, any sex, with Sedentary Behavior or Mental Health Wellness 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The on-going Wuhan coronavirus (COVID-19) outbreak has become the world's leading health headline and is causing major panic and public concerns. On January 30, 2020, the World Health Organization (WHO) declared that the new coronavirus outbreak as a Public Health Emergency of International Concern; and March 11, 2020, characterized COVID-19 as a pandemic. On March, 13, Europe become epicenter of the pandemic all countries in South America had been infected with at least one case. Health authorities, including WHO, have issued safety recommendations for taking simple precautions to reduce exposure to and transmission of the virus. Home stay is a fundamental safety step that can limit infections from spreading widely. Unfortunately, the mandated directives against travelling and participating in outdoor activities will inevitably disrupt the routine daily activities of tens of millions of people. Prolonged home stays may lead to widespread fear and panic, anxiety and depression, which in turn can lead to a sedentary lifestyle. Thus, while quarantine is a safe and priority measure, may have unintended negative consequences. These efforts to avoid human-to-human transmission of the virus may lead to spend excessive amounts of time sitting, reclining or lying down for screening activities (games, television, mobile devices); reducing energy expenditure that, consequently, lead to an increased in a range of chronic health conditions. Therefore, there is a strong health rationale for continuing physical activity in the home to stay healthy and prevent a wide range of psychological problems on people during outbreaks of infection. However, currently, there is no sufficient information on the psychological impact and mental health of the general public during the peak of the COVID-19 epidemic and a timely understanding of mental health status is urgently needed for society. To our knowledge, there are no research examining the psychological and social impact on COVID-19 on the general population. The aim of this research is to determinate the psychological responses in general population in order to understand the anxiety, depression and stress level during Coronavirus Disease (COVID-19) confinement period, and how the level of physical activity development during this exceptional period could be influence.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. [Influence of physical activity during outbreak on psychological states in adults in the Covid-19 pandemic: a study protocol.]
    Camacho-Cardenosa A, Camacho-Cardenosa M, Merellano-Navarro E, Trapé ÁA, et al · · 2020 · cited 1× · PMID 32527993
  2. The Impact of Government Lockdowns on the Mental Health of the General Population: A Systematic Review and Meta-analysis.
    Okazaki Y, Tsujimoto Y, Yamada K, Saka N, et al · · 2025 · PMID 40453305 · DOI 10.7759/cureus.83249

Verify or expand the search:

Other trials of Online Survey

Trials testing the same drug.

Other recruiting trials for Sedentary Behavior

Currently open trials in the same condition.

Other University of Extremadura trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04352517.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing